Platelet IκB Kinase-β Deficiency Increases Mouse Arterial Neointima Formation Via Delayed Glycoprotein Ibα Shedding

Shujian Wei,Huan Wang,Guoying Zhang,Ying Lu,Xiaofei An,Shumei Ren,Yunmei Wang,Yuguo Chen,James G. White,Chunxiang Zhang,Daniel I. Simon,Chaodong Wu,Zhenyu Li,Yuqing Huo
DOI: https://doi.org/10.1161/atvbaha.112.300781
2013-01-01
Abstract:Objective-On the luminal surface of injured arteries, platelet activation and leukocyte-platelet interactions are critical for the initiation and progression of arterial restenosis. The transcription factor nuclear factor-kappa B is a critical molecule in platelet activation. Here, we investigated the role of the platelet nuclear factor-kappa B pathway in forming arterial neointima after arterial injury.Methods and Results-We performed carotid artery wire injuries in low-density lipoprotein receptor-deficient (LDLR-/-) mice with a platelet-specific deletion of I kappa B kinase-beta (IKK beta) (IKK beta(fl/fl)/PF4(cre)/LDLR-/-) and in control mice (IKK beta(fl/fl)/LDLR-/-). The size of the arterial neointima was 61% larger in the IKK beta(fl/fl)/PF4(cre)/LDLR-/- mice compared with the littermate control IKK beta(fl/fl)/LDLR-/- mice. Compared with the control mice, the IKK beta(fl/fl)/PF4(cre)/LDLR-/- mice exhibited more leukocyte adhesion at the injured area. The extent of glycoprotein Iba shedding after platelet activation was compromised in the IKK beta-deficient platelets. This effect was associated with a low level of the active form of A Disintegrin And Metalloproteinase 17, the key enzyme involved in mediating glycoprotein Ib alpha shedding in activated IKK beta-deficient platelets.Conclusion- Platelet IKK beta deficiency increases the formation of injury-induced arterial neointima formation. Thus, nuclear factor-kappa B-related inhibitors should be carefully evaluated for use in patients after an arterial intervention. (Arterioscler Thromb Vasc Biol. 2013;33:241-248.)
What problem does this paper attempt to address?